Europe is heading down the wrong path on AI,” global affairs chief Joel Kaplan wrote in a post on LinkedIn Friday.

EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) ...

In a game that told a different tale from what the Major League Soccer table had been telling for weeks, Philadelphia Union ...